<DOC>
	<DOCNO>NCT00597701</DOCNO>
	<brief_summary>The purpose study determine subject alcohol withdrawal receive oral baclofen , plus standard benzodiazepine therapy , experience less severe withdrawal symptom receive placebo plus standard benzodiazepine therapy.Subjects alcohol withdrawal syndrome ( AWS ) receive baclofen plus standard benzodiazepine therapy experience few complication AWS ( measure use additional sedative , restraint , and/or intensive care unit [ ICU ] admission ) compare subject receive placebo plus standard benzodiazepine therapy .</brief_summary>
	<brief_title>Treating Alcohol Withdrawal With Oral Baclofen</brief_title>
	<detailed_description>Alcohol use ubiquitous American society . 83 % Americans ever consume alcohol , 51 % lst month . The average American consumes 2.18 gallon ethanol yearly . Alcohol related morbidity mortality stagger problem USA . Symptoms alcohol withdrawal occur alcohol central nervous system depressant ; abrupt withdrawal unmasks compensatory overactivity certain part nervous system , include sympathetic autonomic outflow . 5 % patient undergo alcohol suffer Delirium Tremors ( DTs ) , syndrome characterized hallucination , disorientation , tachycardia , hypertension , low grade fever , agitation , diaphoresis . DTs typically begin 48-96 hour last drink last 1 5 day . DTs require hospitalization vigorous activity ICU setting . The successful drug treatment alcohol withdrawal find benzodiazepine . Symptom trigger treatment find effective fix dose treatment result less drug use overall , trend toward short duration withdrawal treatment . Baclofen use orally treatment spasticity result multiple sclerosis , spinal cord injuries/diseases intrathecally spasticity related cerebral palsy , spinal cord injury , amyotrophic lateral sclerosis ( ALS ) . Its propose benefit alcohol withdrawal may reduce voluntary alcohol intake , alcohol craving , may suppress intensity alcohol withdrawal treatment .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Alcohol Withdrawal Delirium</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<criteria>Meet Diagnostic Statistical Manual , 4th version , revise ( DSMrIV ) criteria alcohol withdrawal syndrome ( AWS ) . Be inpatient St. Mary 's Medical Center ( SMMC ) Miller Dwan Medical Center ( MDMC ) time study enrollment . Have alcohol withdrawal score measure standard SMMC MDMC inpatient protocol sufficient trigger use benzodiazepine withdrawal therapy . Agree abstain alcohol duration study . Be able provide inform consent . The patient must active drug dependence addition alcohol . Be unwilling unable forgo alcohol duration study . Be use baclofen time study enrollment . Be use benzodiazepine reason acute alcohol withdrawal syndrome time study enrollment . know baclofen benzodiazepine sensitivity . Be unable take oral ( PO ) med . Be unable complete one two consenting procedure . Be pregnant breastfeeding . Have serum creatine level &gt; 2.0 . Have history non alcoholic withdrawal seizure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Alcohol withdrawal</keyword>
	<keyword>Delirium tremor</keyword>
</DOC>